Search Within

Sergio Andres Giralt

  1. "Alan Hanash"
Formats
  1. Meeting Abstract (11)
  2. Journal Article (9)
Groups
  1. Bone Marrow Transplant (20)
  2. Center for Hematologic Malignancies (20)
  3. Department of Medicine (20)
  4. GSK Faculty (20)
  5. Hematologic Malignancies, Division of (20)
  6. Human Oncology and Pathogenesis Program (20)

More Groups

People
  1. Alan Hanash (20)
  2. Doris Ponce (17)
  3. Miguel-Angel Perales (17)
  4. Juliet Barker (16)
  5. Marcel Van Den Brink (14)
  6. Esperanza Papadopoulos (11)

More People

Years
  1. 2023 (3)
  2. 2022 (1)
  3. 2020 (4)
  4. 2019 (1)
  5. 2018 (1)
  6. 2016 (2)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (9)
  2. Blood (8)
  3. Blood Advances (1)
  4. Journal of Clinical Investigation (1)
  5. Science Translational Medicine (1)
Publishers
  1. American Society of Hematology (9)
  2. Elsevier Inc. (9)
  3. American Association for the Advancement of Science (1)
  4. American Society for Clinical Investigation (1)

Results (20)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Use of a tissue-targeting recombinant human interleukin-22 fusion molecule (F-652) for the treatment of advanced refractory lower GI acute GVHD
    Meeting Abstract

    Satta, T.; Papadopoulos, E. B.; Gyurkocza, B.; Susman, P.; Singh, A.; Calafiore, M.; Giralt, S. A.; Perales, M. A.; Chen, J.; Li, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouse
    Journal Article

    DeWolf, S.; Elhanati, Y.; Nichols, K.; Waters, N. R.; Nguyen, C. L.; Slingerland, J. B.; Rodriguez, N.; Lyudovyk, O.; Giardina, P. A.; Kousa, A. I.; more...
    Science Translational Medicine (2023)

    Fulltext@MSK | Save
  • A phase 2 study of interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract
    Journal Article

    Ponce, D. M.; Alousi, A. M.; Nakamura, R.; Slingerland, J.; Calafiore, M.; Sandhu, K. S.; Barker, J. N.; Devlin, S.; Shia, J.; Giralt, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Tracking immune reconstitution in the bone marrow following allogeneic hematopoietic transplantation in humans reveals early dominance of innate lymphoid populations
    Meeting Abstract

    DeWolf, S.; Kuttiyara, J.; Vinci, P.; Slingerland, J.; Marcello, L. T.; Giardina, P. A.; Donohoe, W.; Lin, R. J.; Papadopoulos, E. B.; Gyurkocza, B.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • TCR repertoires in graft-versus-host-disease (GVHD)-target tissues reveals tissue specificity of the alloimmune response
    Meeting Abstract

    DeWolf, S.; Nichols, K.; Nguyen, C. L.; Giardina, P. A.; Slingerland, J. B.; Elias, H.; Kappangantula, R.; Baez, P.; Murali, R.; Hayashi, A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • High progression-free survival after intermediate intensity double unit cord blood transplantation in adults
    Journal Article

    Barker, J. N.; Devlin, S. M.; Naputo, K. A.; Skinner, K.; Maloy, M. A.; Flynn, L.; Anagnostou, T.; Avecilla, S. T.; Scaradavou, A.; Cho, C.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Addition of tocilizumab to cyclosporine-a/ mycophenolate mofetil (CSA/MMF) graft-vs-host disease (GVHD) prophylaxis significantly abrogates pre-engraftment syndrome (PES) & severe acute GVHD after adult double unit cord blood transplantation (dCBT)
    Meeting Abstract

    Politikos, I.; Maloy, M. A.; Devlin, S. M.; Naputo, K.; Bhatt, V.; Skinner, K.; Cho, C.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
    Journal Article

    Prockop, S.; Doubrovina, E.; Suser, S.; Heller, G.; Barker, J.; Dahi, P.; Perales, M. A.; Papadopoulos, E.; Sauter, C.; Castro-Malaspina, H.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • Addition of tocilizumab to cyclosporine/ MMF for acute graft-vs-host disease (aGVHD) prophylaxis in adult double unit cord blood transplant (dCBT) recipients: Promising preliminary results of a phase II clinical trial
    Meeting Abstract

    Politikos, I.; Maloy, M. A.; Devlin, S. M.; Naputo, K.; Bhatt, V.; Cho, C.; Giralt, S. A.; Gyurkocza, B.; Hanash, A. M.; Papadopoulos, E. B.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Therapeutic cyclosporine-a (CSA) levels in the first 7 days after cord blood transplantation (CBT) are critical to prevent severe acute graft-versus-host disease (aGVHD)
    Meeting Abstract

    Bhatt, V.; Politikos, I.; Devlin, S. M.; Jacob, A. G.; Maloy, M.; Naputo, K.; Afuye, A.; Scaradavou, A.; O'Reilly, R. J.; Castro-Malaspina, H.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save